Teleflex lines up $525M to buy hemostat specialist Z-Medica; CMS competitive bidding process fails to drive expected savings, sparking rethink; Smith & Nephew lays path to 10% growth for acquired Integra assets
The renal care business continues to grow during the pandemic but lower ER utilization and fewer hospitalizations, particularly in the U.S., hurt revenues by more than $65 million in the quarter.
The medtech predicts the trauma surgery and emergency medicine-focused products will begin adding up to $70 million in revenue next year, providing growth drivers outside its key interventional urology segment.
While Needham analysts contend one action removes an overhang for Inogen, Invacare and ResMed, those at Jefferies see a "major negative" in the agency's determination to lower rates outlined in a proposed rule.
The medtech is moving deeper into the extremity orthopaedics turf fought over by the likes of Zimmer Biomet and Stryker acquisition target Wright Medical.
MedTech Dive provides in-depth journalism and insight into the most impactful news and trends shaping medical technology. The newsletters and website cover topics such as medical devices, diagnostics, digital health, regulation/compliance, R&D, M&A and more.
Medtech Dive is a leading publication operated by Industry Dive. Our business journalists spark ideas and shape agendas for 10+ million decision makers in competitive industries.
This email is optimized for display on mobile phones. MedTech Dive: Daily Dive is a product of Industry Dive, Inc.. 1575 Eye St NW, 4th Floor, Washington, DC 20005. We value your privacy. We won't share your email address with anyone else without your permission. This message was sent to [email protected]. You can unsubscribe anytime. See our full privacy policy.
